Development of a novel in ovo model for the screening of anti-inflammatory drugs : implications for the cancer therapies
Paul Garcia(Centre National de la Recherche Scientifique)
HAL (Le Centre pour la Communication Scientifique Directe)
June 3, 2024
Cited by 0
Related Papers
Liver cancer <i>in ovo</i> models for preclinical testing
|The FASEB Journal|2024|2